IPOSchedule
EN
EnglishDeutschFrançais
2026 offering

Aspen Neuroscience IPO

Aspen Neuroscience develops autologous stem cell therapies for neurodegenerative diseases.

  • ASPE
  • Nasdaq Global Select Market
  • United States
  • Healthcare
Filed 9 Oct 2026

Offering in progress. A listing date has not been announced, and proposed terms may change.

Last verified 23 Oct 2026

Company overview

Aspen Neuroscience website

Aspen Neuroscience is a clinical-stage biotechnology company focused on regenerative medicine. Its lead candidate, sasineprocel, is an investigational autologous cell therapy being evaluated for Parkinson’s disease.

Company country
United States

Offering details

Base offering, before overallotment

Exchange
Nasdaq Global Select Market
Ticker
ASPE

IPO timeline

  1. Registration filedAspen Neuroscience files for an IPO
  2. Proposed terms published

Filings and documents

Other IPO profiles

Industrials01

VME Companies

VME Companies provides engineering, procurement and construction services and modular process systems and equipment.

IPO valuation$276M – $345M
Filings Nasdaq Capital MarketIPO
Industrials02

Helio Corp /FL/

Helio Corporation is a holding company providing technology, engineering, and research and development services.

Listing valuation$29.5M – $36.8M
Filings Nasdaq Capital MarketUplisting
Healthcare03

Neuro Spectrum Insights

Neuro Spectrum Insights develops software to support autism diagnosis through MRI image analysis.

IPO valuation$60.4M – $75.4M
Filings NYSE AmericanIPO